scispace - formally typeset
R

Robert A. Rosenheck

Researcher at Yale University

Publications -  993
Citations -  58354

Robert A. Rosenheck is an academic researcher from Yale University. The author has contributed to research in topics: Mental health & Veterans Affairs. The author has an hindex of 114, co-authored 963 publications receiving 54357 citations. Previous affiliations of Robert A. Rosenheck include Eastern Virginia Medical School & The Feinstein Institute for Medical Research.

Papers
More filters
Journal ArticleDOI

Residential Environment and Quality of Life Among Seriously Mentally Ill Residents of Board and Care Homes

TL;DR: Satisfaction with living situation among seriously mentally ill residents of board and care homes may be enhanced by making the social climate more positive, and reducing conflict within the home.
Journal ArticleDOI

Disability payments and chemical dependence: conflicting values and uncertain effects.

TL;DR: A special section of five data-based papers on the relation of disability payments to chemical dependence is introduced, addressing five questions: Do public support payments worsen substance abuse in vulnerable populations?
Journal ArticleDOI

Bed Closures and Incarceration Rates Among Users of Veterans Affairs Mental Health Services

TL;DR: Substantial proportions of mental health system users were incarcerated during the study period, especially younger men and those with both substance use and mental health disorders, and rates of incarceration were similar across health care systems.
Journal ArticleDOI

Outcomes of supported housing for homeless veterans with psychiatric and substance abuse problems.

TL;DR: Prior residential treatment appears to have little effect on treatment outcomes among formerly homeless veterans placed into permanent supported housing programs providing indirect support for the direct placement supported housing model.
Journal ArticleDOI

Substance use and assignment of representative payees

TL;DR: In this paper, the authors suggest guidelines for determining when recipients with comorbid substance use disorders are incapable of managing their benefit funds and propose guidelines for assigning representative payees to such individuals.